Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Flexi Cap Fund median (49 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 02 Jan 2013 – 20 Aug 2026. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one. Nifty 500 history starts 25 Jul 2016, so that benchmark is not plotted over this window — pick a shorter range to see it.
View as table
| Date | Union Flexi Cap Fund |
|---|---|
| 02 Jan 2013 | ₹100.00 |
| 21 Feb 2014 | ₹104.56 |
| 12 Apr 2015 | ₹156.75 |
| 31 May 2016 | ₹139.51 |
| 19 Jul 2017 | ₹169.89 |
| 07 Sep 2018 | ₹174.18 |
| 27 Oct 2019 | ₹166.97 |
| 15 Dec 2020 | ₹204.20 |
| 03 Feb 2022 | ₹286.86 |
| 25 Mar 2023 | ₹273.81 |
| 12 May 2024 | ₹396.17 |
| 01 Jul 2025 | ₹460.95 |
| 20 Aug 2026 | ₹441.97 |
| Metric | Union · Direct · IDCW NAV ₹48.44 Very High risk ★★★☆☆ | Category median Flexi Cap Fund · 49 funds |
|---|---|---|
| -2.75% | +2.34% | |
| +10.41% | +12.85% | |
| +10.52% | +10.36% | |
| +11.34% | +8.08% | |
| +11.52% | +11.66% | |
| +8.94% | — | |
| +12.59% | +12.67% | |
| +12.42% | +11.75% | |
| +12.30% | +9.39% | |
| Risk | ||
| 14.56% | 14.56% | |
| 0.27 | 0.38 | |
| 0.35 | 0.50 | |
| -37.98% | -33.86% | |
| Nifty 500 | — | |
| -1.29% | +0.65% | |
| 0.93 | 0.98 | |
| 87.6% | 100.2% | |
| 89.9% | 97.9% | |
| 1.57% | 0.86% | |
| ₹2,288Cr | ₹4,009Cr | |
| 1.00% | — | |
| None | — | |
| ₹500 | — | |
| ₹1.00K | — | |
| 43% | 37% | |
| Gaurav Chopra | — | |
| 02 Jan 2013 | — | |
| 69 | — | |
| 32.0% | — | |
| 4.0% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.